Curo Bio SciencesEarly StageCuro Bio Sciences Private LimitedCreating a world where non-invasive prognosis and diagnosis is painless, affordable and accessible for all.
Our first test kit is to detect Oral precancerous conditions in just 15 minutes. Can detect even before the appearance of any tumor or lesion in the oral cavity, larynx or pharynx.
Startup Description
Developing the next generation of prognostics & advanced diagnostics medical devices for early stage detection of multiple cancers in a non invasive and painless manner through saliva.
Product Screenshots
Business Model
Our business model revolves around distributing our cancer test kit through various channels across our target region. We aim to penetrate hospitals, labs, dental clinics, government health checkup camps, corporates for employee healthcare activities, as well as NGOs and CSR initiatives. Key to our strategy is forging partnerships with healthcare professionals, particularly doctors, who would recommend our kit to their patients. By leveraging these diverse distribution channels and healthcare networks, we intend to reach a wide audience and make our cancer test kit accessible to those who need it most, thereby contributing to early detection and improved cancer outcomes.
Customers
based in
South Asia, Southeast Asia
Business
Modal Type
Marketplace
Type of
Sales
B2B
Competitors
EasyCheck, OncoStem, Sascan
Teams
Shubhendra Singh
Founder & CEO
Deovrat Begde
Co founder & CSO
Tell us a bit about how founding team knows
each other.
Dr Deovrat is the mentor at and early believer in Erly Sign.
Why did you decide to start this
company?
Later the detection of cancer, lesser the chances of successful treatment. We aim to change that.
Are all the founders full-time on this
project?
Yes
Looking for an
opportunity to invest in companies
like Curo Bio Sciences?
